Skip to main content

Table 3 Turkey, reference countries and UK pricing and reimbursement methods

From: Comparison of pharmaceutical pricing and reimbursement systems in Turkey and certain EU countries

Country Turkey France Greece Spain Italy Portugal UK
Pricing policy Statutory pricing Price negotiation Statutory pricing Statutory pricing Price negotiation Statutory pricing Margine control
Direct price controls Org Gen Org Gen Org Gen Org Gen Org Gen Org Gen Org Gen
Yes Yes Yes No Yes Yes Yes No Yes No Yes No No Yes
Reference pricing Yes Yes Yes Yes Yes Yes Only for PPRS-excluded medicines
External reference pricing Yes Yes Yes Yes Yes Yes No
Internal reference pricing Yes Yes Yes Yes Yes Yes Yes
Different pricing for generics Yes Yes Yes Yes Yes Yes Yes
Price control All medicines Only for reimbursed medicines All medicines Only for reimbursed medicines Only for reimbursed medicines All prescription medicines Only for medicines in NHS list
Level of price control Manufacturer price Manufacturer price Manufacturer price Manufacturer price Manufacturer price Manufacturer price NHS list price
Reimbursement catagories In general 41% and 28% discount. 18% and 10% available for 20 year old medicines and generics generally Major (65%), moderate (35%), weak (0%) 0, 10 and 25% 100, 90, 60 and 0% Class A and class H 100%, Clas C and class C-bis 0% Class A 95%, B 69%, C 37%, D 15% After PPRS price negotiation 100%
Differences for originals and generics on reimbursement level Yes No No Yes No No Yes
Negative positive list Yes Yes No Yes No Yes Yes
Decision taking committees Reimbursement commission of social security institution (SSI) Committee of transparancy and economics Transparancy committee Inter-ministerial pricing committee Technical committee under italian medicines agency (AIFA) Portugal medicines agency Health department of PPRS